Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine versus fentanyl in hospitalized patients with COVID-19
IRCT20150725023332N4Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in coronavirus disease 2019 (COVID-19) comparing Morphine with Fentanyl (2 arms). Primary endpoints: Respiratory indicators, Inflammatory indicators and 2 more. Started Apr 2020; status: completed.
02
Drugs
morphinefentanyl
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20150725023332N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150725023332N4.